Open AccessStem Cell Therapy for Parkinson’s disease: Are Double-Blind Randomized Control Trials the Best Design for Quantifying Therapy Outcomes?
Author(s) -
Stephen Polgar,
Leila Karimi,
Meg E. Morris
Publication year - 2013
Publication title -
journal of neurology and neurophysiology
Language(s) - English
Resource type - Journals
ISSN - 2155-9562
DOI - 10.4172/2155-9562.1000170
Subject(s) - parkinson's disease , stem cell therapy , disease , medicine , cell therapy , randomized controlled trial , clinical trial , bioinformatics , stem cell , pathology , biology , mesenchymal stem cell , genetics